Rubinstein et al. (2004) and Nambiar et al. (2019), using murine tumour models, independently demonstrated that Gal1 facilitates tumour immune evasion by selectively modulating T cell responses [9,23]. This evidence concerns the gene LGALS1 and neoplasm.